National Registry of Epilepsy in Mexico
1 other identifier
observational
15,000
0 countries
N/A
Brief Summary
The National Registry of Epilepsy in Mexico aims to be an observational, multicenter, and nationwide study about Epilepsy in Mexico. This project is proposed as the first registry about the diagnosis and treatment of epilepsy in Mexico. The participation of major health institutions, both public and private, of each state to ensure that the registry is representative of the country is planned.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2020
CompletedFirst Submitted
Initial submission to the registry
May 7, 2020
CompletedFirst Posted
Study publicly available on registry
May 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2021
CompletedMay 12, 2020
May 1, 2020
1 year
May 7, 2020
May 7, 2020
Conditions
Outcome Measures
Primary Outcomes (6)
Number of patients treated for epilepsy in 70 public hospitals in the health sector in Mexico, divided by age groups.
We have a database that will be used to capture patients separated by age, newborn, pediatric age and adults, analyzing how many belong to each age group with an individual accounting to know the total absolute number.
Four months
To know the type of epileptic crisis, the type of epilepsy and the type of epileptic syndrome presented by patients who are treated for this disease in 70 public hospitals in the health sector in Mexico.
We have a database that will be used to capture patients divided by type of epileptic crisis that they present, both focal onset, generalized onset, or unknown onset. By the type of epilepsy that they present either focal, generalized, mixed, both focal and generalized or unknown epilepsy. And those who present characteristics of an epileptic syndrome register them. In this way we will have absolute numbers for each category of these three items.
Four months
Number of patients with epilepsy, separated by etiologies treated in 70 public hospitals in the health sector in Mexico.
We have a database that will be used to capture patients separated by six specific etiologies, as currently recommended by the International League Against Epilepsy, structural, genetic, immune, infectious, metabolic or unknown, accounting for those who register each group to know the total absolute number.
Four months
To know the type of comorbidity presented by patients treated for Epilepsy in 70 public hospitals in the health sector in Mexico.
We have a database that will be used to capture the different comorbidities that patients present, some of them may have more than one comorbidity and it is interesting to quantify which are the most frequent of this group of patients treated in hospitals in the sector. public from Mexico regardless of the age of the patient, although later a more frequent sub-analysis can be made by age group and comorbidity.
Four months
To know the type of antiepileptic drugs that have been used and are currently used by patients treated for Epilepsy in 70 public hospitals in the health sector in Mexico.
We have a database that will be used to capture the drugs previously used by patients with epilepsy and what has been the reason for not taking them anymore, either due to lack of effectiveness or adverse effect, indicating by devices and systems in where it presented the adverse effect. In the same way, the antiepileptic drugs used by patients with epilepsy to control their disease will be known and accounted for.
Four months
Number of patients in spatial groups such as those in the newborn, pregnancy, with epilepsy surgery and with concomitant diseases treated by Epilepsy in 70 public hospitals in the health sector in Mexico.
We have a database that will be used to capture patients separated by age, newborn, pediatric age and adults, analyzing how many belong to each age group with an individual accounting to know the total absolute number.
Four months
Eligibility Criteria
Candidates for the registry are those patients of any gender and any age who present an Epilepsy diagnosis according to the current definition of the ILAE 2014.
You may qualify if:
- Patients seen in an institution in the public sector of Mexico that belong to the Epilepsy Priority Program
- Informed consent and assent of participation in the project
- Patients with any form of epilepsy
- Patients seen by a Pediatric Neurologist or Neurologist
You may not qualify if:
- Patients who decide at any time not to participate
- Incomplete data of their disease
- Non-epileptic seizures
- Inadequate information from the patient, family member or informant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Programa Prioritario de Epilepsialead
- Medicaweb, S.A.C.V.collaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2020
First Posted
May 12, 2020
Study Start
May 1, 2020
Primary Completion
May 1, 2021
Study Completion
November 1, 2021
Last Updated
May 12, 2020
Record last verified: 2020-05